ロード中...
Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct ligated rats and human hepatic cells
Cholestasis leads to liver cell death, fibrosis, cirrhosis, and eventually liver failure. Despite limited benefits, ursodeoxycholic acid (UDCA) is the only FDA approved treatment for cholestatic disorders. Retinoic acid (RA) is a ligand for nuclear receptors, which modulate bile salt homeostasis. RA...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3069505/ https://ncbi.nlm.nih.gov/pubmed/21274875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.24047 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|